Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Stan Yakatan, CEO of Katan Associates, to do Keynote at the Antibody Partnering & Technology SummitStan Yakatan, the Chairman and Chief Executive Officer at Katan Associates, is to give a keynote presentation on the recent approval of a follow-on version of Pfizer’s Genotropin (recombinant human growth hormone)
By: , Katan Associate, Antibody, Genotropin Yakatan’s session will describe many of the key scientific challenges facing the nascent “biogenerics” After 30 years as a successful CEO, entrepreneur, and operational manager, Stan Yakatan has dedicated the last 12 years of his career to sharing his experiences with management teams interested in building technology based companies. His experience as a "C" level executive is far reaching he has served in such a capacity with: New England Nuclear, EI Dupont, ICN Pharma, New Brunswick Scientific and Biosearch. These experiences have provided him with management skills and a corporate finance acumen that he enjoys sharing with others. Stan has founded or co-founded in excess of 15 companies in the United States, Canada, Israel, France and Germany. In many cases he has also served as the initial CEO, and Chairman of these companies. In his career, he has advised several of the world's leading venture capital firms including TVM (Germany), Ventana (USA), MSP (USA), and Biocapital (Canada). During the decade of the 1990's Biocapital was the most successful venture capital fund in Canada. # # # GTCbio 434 W. Foothill Blvd. Monrovia, CA 91016 Tel: (626) 256-6405 fax: (626) 256-6460 email: infogtcbio@gtcbio.com http://www.gtcbio.com/ End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|